Loading…
Prostate Cancer Misdiagnosis Elimination Act of 2017
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
91pct
201d open
vs 7,393 other HR bills in the 115th — cohort avg 50d
Prostate Cancer Misdiagnosis Elimination Act of 2017 This bill provides for Medicare coverage of a DNA Specimen Provenance Assay clinical diagnostic laboratory test following a positive prostate cancer biopsy.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2018 · fourth_quarter · Medicare/Medicaid
H.R. 2557/ S. 2067 - Prostate Cancer Misdiagnosis Elimination Act of 2017. H.R. 6886 - HEARTS Act of 2018.
Client expense: Not reported · Firm income: $20,000
Placed on the Union Calendar, Calendar No. 331.
Committee on Ways and Means discharged.
Committee on Ways and Means discharged.
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 115-449, Part I.
Congress.gov source codes: 5000, H12200
Ordered to be Reported (Amended) by Voice Vote.
Committee Consideration and Mark-up Session Held.
Forwarded by Subcommittee to Full Committee by Voice Vote .
Subcommittee Consideration and Mark-up Session Held.
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Health.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · fourth_quarter · Medicare/Medicaid
Support for H.R. 2557 / S. 2067 - Prostate Cancer Misdiagnosis Elimination Act of 2017. Support for H.R. 6886 - HEARTS Act of 2018.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · third_quarter · Medicare/Medicaid
H.R. 2557/ S. 2067 - Prostate Cancer Misdiagnosis Elimination Act of 2017. H.R. 6886 - HEARTS Act of 2018.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · third_quarter · Medicare/Medicaid
Support for H.R. 2557 / S. 2067 - Prostate Cancer Misdiagnosis Elimination Act of 2017. Support for H.R. 6886 - HEARTS Act of 2018.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · third_quarter · Health Issues
Legislation affecting medical diagnostics and prostate cancer. H.R. 2557/S. 2067 - Prostate Cancer Misdiagnosis Elimination Act of 2017; and H.R. 6886 - HEARTS Act of 2018.
Client expense: Not reported · Firm income: Not reported
2018 · second_quarter · Medicare/Medicaid
Support for H.R. 2557 / S. 2067 - Prostate Cancer Misdiagnosis Elimination Act of 2017.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · first_quarter · Medicare/Medicaid
Support for H.R. 2557 / S. 2067 - Prostate Cancer Misdiagnosis Elimination Act of 2017. Support for Medicare coverage of prostate cancer diagnostic test in H.R. 1892 - Bipartisan Budget Act.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2017 · fourth_quarter · Medicare/Medicaid
Medicare coverage of diagnostic test. Support for H.R. 2557 / S. 2067 - Prostate Cancer Misdiagnosis Elimination Act of 2017.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2017 · third_quarter · Medicare/Medicaid
Medicare coverage of diagnostic test. Support for H.R. 2557 - Prostate Cancer Misdiagnosis Elimination Act of 2017.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2017 · second_quarter · Medicare/Medicaid
Medicare coverage of diagnostic test. Support for H.R. 2557 - Prostate Cancer Misdiagnosis Elimination Act of 2017.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Congress.gov source codes: H11100, H11100-A
Introduced in House
Congress.gov source codes: 1000, Intro-H
| Referred to |
| May 19, 2017 |
| Energy and Commerce Committee | House | Referred to | May 19, 2017 |
| Republican |
| IN |
| Markwayne Mullin | Republican | OK |
| Susan W. Brooks | Republican | IN |